Macpherson Edward Clouston Acquires 50,000 Shares of MIRA

Macpherson Edward Clouston recently purchased 50,000 shares of MIRA on June 12, 2026. The transaction was not part of a pre-planned trading program. At the time of the purchase, MIRA shares were trading around $0.93.

Other Institutional Activity in MIRA

Vanguard Capital Management LLC made a significant move by acquiring 693,912 shares of MIRA, valued at approximately $742,486. Geode Capital Management, LLC also increased its holdings by 18,012 shares, bringing its total to 290,890 shares worth about $311,251. Meanwhile, BlackRock, Inc. added 2,577 shares, ending with 112,346 shares valued at $120,210. On the other hand, Suncoast Equity Management reduced its position by 12,644 shares, leaving it with 90,645 shares valued at $96,990.

Insider Buying and Selling at MIRA Pharmaceuticals, Inc.

On June 12, 2026, several insiders including Macpherson Edward Clouston, Del Giudice Matthew Paul, Whalen Matthew Pratt, and Shekhat Denil Nanji each purchased 50,000 shares of MIRA. These transactions were not part of any pre-planned trading programs. Earlier, on December 17, 2025, CEO and Chairman Erez Aminov made a substantial acquisition of 3,155,170 shares.

Bottom Line

Insider purchases like those by Macpherson Edward Clouston can signal confidence in MIRA's prospects. The activity among institutional investors, including Vanguard Capital Management and BlackRock, Inc., also highlights interest in the company. While insider and institutional moves provide insights, they do not necessarily predict future performance.